Myriad Genetics (MYGN) Other Working Capital Changes (2009 - 2026)

Myriad Genetics (MYGN) has 18 years of Other Working Capital Changes data on file, last reported at $9.7 million in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $9.7 million, up 340.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.3 million (up 630.0% YoY), and the FY2025 annual result was -$200000.0, down 113.33% from the prior year.
• Other Working Capital Changes grew to $9.7 million in Q1 2026 per MYGN's latest filing, from -$1.8 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $9.7 million in Q1 2026 and troughed at -$5.3 million in Q2 2022.
• A 5-year average of $541176.5 and a median of $300000.0 in 2024 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes sank 3900.0% in 2022, then surged 1200.0% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at -$4.0 million in 2022, then increased by 20.0% to -$3.2 million in 2023, then surged by 109.38% to $300000.0 in 2024, then slumped by 700.0% to -$1.8 million in 2025, then jumped by 638.89% to $9.7 million in 2026.
• Business Quant data shows MYGN's Other Working Capital Changes at $9.7 million in Q1 2026, -$1.8 million in Q4 2025, and $1.3 million in Q3 2025.